Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal
Reexamination Certificate
2008-05-27
2008-05-27
Wehbe, Anne M. (Department: 1633)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
Transgenic nonhuman animal
C800S014000, C424S093200
Reexamination Certificate
active
07378569
ABSTRACT:
The invention provides a transgenic animal carrying two transgenes, one encoding a human decay accelerating factor (hDAF) and the other encoding a human heme oxygenase-1 (hHO)-1, which are useful for providing cells, tissues or organs therefrom for xenotransplantation.
REFERENCES:
Cozzi et al., The generation of transgenic pigs as potential organ donors for human, 1995, Nature Medicine, 1:964-966.
Zhang et al., Animal models in xenotransplantation. Exp. Opin. Invest. Drugs, 2000, 9:2051-2068.
Logan et al., Potential use of genetically modified pigs as organ donors for transplantation into humans. Clin Exp Pharmacol Physiol. Dec. 1999;26(12):1020-5. Review.
Murphy, L.J and Silha, J.V., Unexpected and unexplained phenotypes in transgenic models. Growth Hormone and IGF Research, 10:233-235, 2000.
Sigmund. Viewpoint: are studies in genetically altered mice out of control?Arterioscler Thromb Vasc Biol. Jun. 2000;20(6):1425-9. Review.
Hammer et al.,Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. Nov. 30, 1990;63(5):1099-112.
Kappel, Regulating gene expression in transgenic animals. Current Biology, 3:548-553, 1992.
Williams and Wagner, Transgenic animals in integrative biology: approaches and interpretation. J. Appl. Physiol., 88:1119-1126, 2000.
Niemann, Transgenic farm animals get off the ground. 1997, Transg. Res. 7:73-75.
Nebert et al., How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction and development, in environmental toxicity, cancer, and oxidative stress. Biochem Pharmacol. Feb. 7, 1997;53(3):249-54. Review.
McCurry et al., Human complement regulatory proteins swine-to-primate cardiac xenografts from humoral injury.Nat Med. May 1995;1(5):423-7.
Yet SF aet al., Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. Jul. 20, 2001;89(2):168-173.
Cooper, “Is Xenotransplantation a realistic clinical option?”,Transplant. Proc., 1992: 24:2393-2396.
Nowak, “Xenotransplants set to resume”,Science, 1994: 266:1148-1151.
Cozzi, “Expression of human decay accelerating factor in transgenic pigs”,Transplant. Proc., 1994; 26:1402-1403.
McCurry, “Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury”,Nature Med., 1995; 1:423-427.
Fodor, “Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneica hyperacute organ rejection”,Proc. Natl. Acad. Sci., 1994; 91:11153-11157.
Schmoeckel, “Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts”,Transplantation, 1996; 62:729-734.
Byrne, “Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage”,Transplantation, 1997; 63:149-155.
Kroshus, “Expression of human CD59 in transgenic pig organs enhance organ survival in an ex vivo xenogeneic perfusion model”,Transplantation, 1997; 61: 1513-1521.
Storck, “Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood”,Transplantation, 1997; 63:304-310.
Pierson, “Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood”,J. Heart and Lung Trans., 1997; 16:231-239.
Diamond, “Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium”,Transplantation, 1996; 61:1241-1249.
Cozzi, “Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts”,Transplant. Proc., 2000; 70:15-21.
Vial, “Life supporting function for over one month of a transgenic porcine heart in a baboon”,J. Heart Lung Transplant, 2000; 19:224-229.
Galili, “The natural anti-gal antibody: evolution and autoimmunity in man”,Immunol. Ser.; 1991; 55:355-373.
Galili, “Man, apes, and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells”,J. Biol. Chem.; 1988; 263:17755-17762.
Larsen, “Isolation of a cDNA encoding a murine UDPgalactose:$\beta $-D-galactosyl-1,4-N-acetyl-D-glucosaminide $\alpha $-1,3-galactosyltransferase: expression cloning by gene transfer”,PNAS, 1989; 86:8227-8231.
Larsen, R., “Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UPD-Gal:β-D-Gal(1,4)-D-GlcNAc α(1,3)-galactosyltransferase cDNA”,J. Biol. Chem., 1990: 265:7055-7061.
Sandrin, M., “Characterization of cDNA clones for porcine α(1,3)galatosyl transferase: The enzyme generating the Galα(1,3)Gal epitope”,Xenotransplantation, 1994; 1:81-88.
Joziasse, D., “Characterization of an α1-3-Gaactosyltransferase Homologue on human chromosome 12 that is organized as a processed pseudogene”,J. Biol. Chem., 1991; 266:6991-6998.
Dai, Y., “Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs”,Nature Biotech., 2002; 20:251-255.
Lai, L., “Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning”,Science, 2002; 295:1089-1092.
Phelps, C., “Production of α-1,3-galactosyltransferase-deficient pigs”,Science, 2002; 299:411-414.
Sharma, A., “Reduction in the level of Gal($\alpha $1,3)Gal in transgenic mice and pigs by the expression of an $\alpha $(1,2)fucosyltransferase”,PNAS, 1996; 93:7190-7195.
Maines, M., “The heme oxygenase system: A regulator of second messenger gases”,Ann. Rev. Pharmacol. Toxicol., 1997; 37:517-554.
Choi, A., “Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury”,Am. Journ. Of Resp. Cell and Molecular. Biol., 1996; 15:9-19.
Poss, K., “Reduced stress defense in heme oxygenase 1-deficient cells”,Proc. Natl. Acad. Sci. of USA, 1997; 94:10925-10930.
Poss, K., “Heme oxygenase 1 is required for mammalian iron reutilization”,Proc. Natl. Acad. Sci. of USA, 1997; 94:10919-10924.
Soares, M., “Expression of heme oxygenase-1 can determine cardiac xenograft survival”,Nature Medicine, 1998; 4:1073-1077.
Yachie, A., “Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency”,J. of Clin. Invest., 1999; 103:129-135.
Sato, K., Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants,J. Immun., 2001; 166:4185-4194.
Pileggi, A., “Heme oxygenase-1 induction in islet cells result in protection from apoptosis and improved in vivo function after transplantation”,Diabetes; 2001; 50:1983-1991.
Otterbein, L., “Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury”,J. of Clin. Invest., 1999; 103:1047-1054.
Amersi, F., “Upregulation of heme oxygenase-1 protects genetically fat zucker rat livers from ischemia/reperfusion injury”,J. Clin. Invest., 1999; 104:1631-1639.
Shiraishi, F., “Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis”,Am. J. Physiol Renal Physiol., 2000; 278:F726-F736.
Minamino, T., “Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia”,PNAS, 2001; 98:8798-8803.
Yet, S., “Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice”,Cir. Res., 2001; 89:168-173.
Medof, M., “Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement”,Proc. Natl. Acad. Sc
Ho Lin-Lin
Huang Kuei-Feng
Lee Chun-Jean
Liu Ming-Shing
Tai Hao-Chih
Animal Technology Institute Taiwan
Leavitt Maria
RothWell, Figg, Ernst & Manbeck P.C.
Wehbe Anne M.
LandOfFree
Transgenic pigs carrying both hHO-1 and hDAF transgenes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic pigs carrying both hHO-1 and hDAF transgenes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic pigs carrying both hHO-1 and hDAF transgenes for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2815641